HK1045262B - Gardos通道拮抗劑 - Google Patents

Gardos通道拮抗劑 Download PDF

Info

Publication number
HK1045262B
HK1045262B HK02106773.8A HK02106773A HK1045262B HK 1045262 B HK1045262 B HK 1045262B HK 02106773 A HK02106773 A HK 02106773A HK 1045262 B HK1045262 B HK 1045262B
Authority
HK
Hong Kong
Prior art keywords
compound
substituent
compounds
ring
acetamide
Prior art date
Application number
HK02106773.8A
Other languages
English (en)
Chinese (zh)
Other versions
HK1045262A1 (en
Inventor
G‧A‧麦克诺顿-史密斯
G‧A‧麥克諾頓-史密斯
G‧C‧里格登
J‧W‧施特克尔
J‧W‧施特克爾
Original Assignee
安克进药物公司
安克進藥物公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 安克进药物公司, 安克進藥物公司 filed Critical 安克进药物公司
Publication of HK1045262A1 publication Critical patent/HK1045262A1/xx
Publication of HK1045262B publication Critical patent/HK1045262B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/65—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/11—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK02106773.8A 1999-02-23 2000-02-10 Gardos通道拮抗劑 HK1045262B (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US13551199P 1999-02-23 1999-02-23
US09/386,601 US6288122B1 (en) 1999-02-23 1999-08-31 Gardos channel antagonists
US09/386,601 1999-08-31
PCT/US2000/003663 WO2000050026A1 (en) 1999-02-23 2000-02-10 Gardos channel antagonists

Publications (2)

Publication Number Publication Date
HK1045262A1 HK1045262A1 (en) 2002-11-22
HK1045262B true HK1045262B (zh) 2005-07-29

Family

ID=26833406

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02106773.8A HK1045262B (zh) 1999-02-23 2000-02-10 Gardos通道拮抗劑

Country Status (16)

Country Link
US (1) US6288122B1 (enExample)
EP (1) EP1158971B1 (enExample)
JP (2) JP4038337B2 (enExample)
KR (1) KR100705726B1 (enExample)
CN (1) CN1193748C (enExample)
AP (1) AP1465A (enExample)
AT (1) ATE370728T1 (enExample)
AU (1) AU762039B2 (enExample)
BR (1) BR0008416A (enExample)
CA (1) CA2371857C (enExample)
DE (1) DE60036093T2 (enExample)
ES (1) ES2291191T3 (enExample)
HK (1) HK1045262B (enExample)
IL (2) IL145012A0 (enExample)
OA (1) OA11838A (enExample)
WO (1) WO2000050026A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003004010A1 (en) * 2001-07-06 2003-01-16 Poseidon Pharmaceuticals A/S Carbonylamino derivatives useful for obtaining immune regulation
ATE400551T1 (de) 2002-01-04 2008-07-15 Neurosearch As Kaliumkanal-modulatoren
WO2003074038A1 (en) * 2002-02-28 2003-09-12 Icagen, Inc. Methods for treating diseases related to intraocular pressure
WO2005003143A1 (en) * 2003-07-03 2005-01-13 Poseidon Pharmaceuticals A/S Novel potassium channel modulators
WO2005003094A1 (en) * 2003-07-03 2005-01-13 Poseidon Pharmaceuticals A/S Diarylmethyl derivatives as potassium channel modulators
US7709533B2 (en) * 2005-02-01 2010-05-04 Icagen, Inc. Imines as ion channel modulators
CN101437403A (zh) * 2005-12-20 2009-05-20 Icagen公司 使用三芳基甲烷化合物的治疗方法
US20100056637A1 (en) * 2005-12-20 2010-03-04 Icagen, Inc. Treatment methods using triaryl methane compounds
JP2010536827A (ja) 2007-08-24 2010-12-02 ノイロサーチ アクティーゼルスカブ ある種の炎症性障害の治療に有用なカルボニルアミノ誘導体
US20090076157A1 (en) * 2007-09-15 2009-03-19 Protia, Llc Deuterium-enriched senicapoc
KR101896430B1 (ko) 2008-04-09 2018-09-10 세루스 코포레이션 적혈구 병원체 불활성화를 위한 개선된 퀀칭 방법
US9428568B2 (en) 2008-11-10 2016-08-30 Boehringer Ingelheim International Gmbh Compositions and methods for modulating cell-cell fusion via intermediate-conductance calcium-activated potassium channels
US10179115B2 (en) 2015-02-20 2019-01-15 The Children's Medical Center Corporation Methods for treating malaria using potassium channel inhibitors
EP3106155A1 (en) 2015-06-15 2016-12-21 Universite d'Aix Marseille Treatment and diagnosis of hereditary xerocytosis
US11439607B2 (en) * 2016-10-25 2022-09-13 Paracelsus Neuroscience I, LLC Use of senicapoc for treatment of neuropathic pain
WO2018162426A1 (en) 2017-03-06 2018-09-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Treatment and diagnosis of hereditary xerocytosis
WO2020198939A1 (zh) * 2019-03-29 2020-10-08 深圳仁泰医药科技有限公司 2,2-双(4-氟苯基)-2-苯乙酰胺的晶型a及其制备方法和应用
US12186286B2 (en) * 2019-07-29 2025-01-07 Paracelsus Neuroscience Llc Use of senicapoc for treatment of stroke
EP4181908A4 (en) * 2020-07-14 2024-03-06 Adimabio LLC COMPOSITIONS COMPRISING GARDOS CHANNEL ANTAGONISTS AND THEIR USES
CN116847838A (zh) 2020-12-11 2023-10-03 桑昆专利有限公司 炎症性贫血的治疗和预防

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5273992A (en) 1992-11-02 1993-12-28 Beth Israel Hospital Assoc. Inc. Method for reducing sickle erythrocyte dehydration and delaying the occurrence of erythrocyte sickling in-situ
WO1997034589A1 (en) 1996-03-20 1997-09-25 President And Fellows Of Harvard College Triaryl methane compounds for sickle cell disease

Also Published As

Publication number Publication date
IL145012A0 (en) 2002-06-30
CN1344158A (zh) 2002-04-10
JP4038337B2 (ja) 2008-01-23
KR20020002393A (ko) 2002-01-09
CA2371857A1 (en) 2000-08-31
DE60036093T2 (de) 2008-05-15
US6288122B1 (en) 2001-09-11
AU2880700A (en) 2000-09-14
IL145012A (en) 2006-12-10
EP1158971A1 (en) 2001-12-05
CN1193748C (zh) 2005-03-23
EP1158971B1 (en) 2007-08-22
HK1045262A1 (en) 2002-11-22
KR100705726B1 (ko) 2007-04-11
WO2000050026A1 (en) 2000-08-31
CA2371857C (en) 2008-07-29
AP2001002268A0 (en) 2001-09-30
AP1465A (en) 2005-09-22
EP1158971A4 (en) 2003-04-16
OA11838A (en) 2005-08-22
JP2007262075A (ja) 2007-10-11
ES2291191T3 (es) 2008-03-01
JP2002537331A (ja) 2002-11-05
AU762039B2 (en) 2003-06-19
DE60036093D1 (de) 2007-10-04
ATE370728T1 (de) 2007-09-15
BR0008416A (pt) 2002-01-29

Similar Documents

Publication Publication Date Title
CN1193748C (zh) Gardos通道拮抗剂
CN85107020A (zh) 烷基亚磺酰胺基苯基烷基胺的制备方法
CN1012433B (zh) 白三烯拮抗剂的制备方法
CN1255136A (zh) 取代的4－芳基亚甲基－2－亚氨基－2,3－二氢噻唑和衍生物及其药学应用
CN1261877A (zh) 4－溴或4－碘苯基氨基苯氧肟酸衍生物及其作为mek抑制剂的用途
CN1034176C (zh) 用于预防和治疗糖尿病并发症的药物组合物的制备方法
CN1589264A (zh) 用于治疗恶性肿瘤的方法
CN1023402C (zh) 制备5-羟色胺拮抗药的方法
CN1079789C (zh) 新的羟肟酸衍生物,包含它们的药物组合物及其制法
CN87100686A (zh) 用作心血管剂的3-烷氧基-2-氨基丙胺类化合物
CN1092074A (zh) 二氮杂䓬衍生物
CN1126990A (zh) 新的(1-苯基-1-杂环基)烷烃衍生物和作为神经保护剂的应用
CN1014515B (zh) 制备mao抑制剂—非芳香族氟烯丙胺的方法
CN1015175B (zh) 苯甲酰胺类抗惊厥剂的制备方法
CN1247537A (zh) 具有5－ht受体活性的磺酰胺化合物
CN1112113A (zh) 新的三唑化合物及其制备方法和用途
CN1976903A (zh) 因子VⅡa抑制剂
CN1177852C (zh) 膦酸二酯衍生物
CN1914169A (zh) 作为环氧合酶－2抑制剂的二芳基－2－(5h)－呋喃酮的氧化氮释放前药
CN1466573A (zh) 5-苯基苄胺化合物、其制备方法以及其合成中间体
CN1249018C (zh) 用于镰状细胞疾病的三芳基甲烷化合物
CN1232388A (zh) 抗疟疾和抗巴贝虫病剂和含有它们的药物组合物
CN1306422A (zh) 用于治疗或预防以异常细胞增殖为特征之疾病的经取代的二苯基茚满酮、茚满和吲哚化合物及其类似物
CN1034710A (zh) 新化合物
CN1170716A (zh) 双－邻位取代的苯甲酰胍、其制备方法、用途及含有它们的药物

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140210